Furthermore, we utilized TIMER2 to investigate the relationship between ME1 expression and the levels of various immune cell infiltrates across all TCGA tumors (Figure 7M) These results suggested that ME1 might influence the heterogeneity of the tumor immune microenvironment by regulating the recruitment and function of specific immune cell subsets, thereby impacting the efficacy of immunotherapy. This evidence concerns the gene ME1 and neoplasm.